Moreover, our inquiry not only scrutinizes the interplay among GTSE1 expression, prognosis, and immune infiltration in pan‐cancer contexts but also discloses, for the inaugural time, the heightened diagnostic efficacy of GTSE1 across 21 distinct cancer types. The gene discussed is GTSE1; the disease is cancer.